Related Experiment Video
Updated: May 25, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
[Kidney diseases: new issues]
1Inserm UMRS702, Tenon Hospital, UPMC université Paris 6, 75970 Paris cedex 20, France. pierreronco@yahoo.fr
Insights
Millions in France have undiagnosed chronic kidney disease (CKD), a major risk for heart problems. Early screening and new treatments are crucial to manage kidney function and reduce cardiovascular risk.
Area of Science:
- Nephrology
- Epidemiology
- Cardiology
Context:
- Chronic kidney disease (CKD) affects 2-4 million people in France, with many unaware of their condition.
- CKD is a significant independent risk factor for cardiovascular mortality and morbidity, escalating with renal failure severity.
- Current evaluation of glomerular filtration rate (GFR) uses MDRD and CKD-EPI equations.
Purpose:
- To advance understanding of CKD epidemiology, risk factors, progression mechanisms, and medical practices.
- To improve early screening for CKD in high-risk populations (diabetes, hypertension, cardiovascular diseases).
- To identify novel therapeutic targets and biomarkers for early intervention and halting CKD progression.
Summary:
- The French CKD-REIN cohort study follows over 3000 patients for 5 years to investigate CKD.
- Focus on improving screening via blood pressure, proteinuria, and serum creatinine measurements.
- Aims to discover new treatments to prevent renal insufficiency and decrease cardiovascular risk.
Impact:
- Enhance knowledge of CKD's burden and progression in France.
- Facilitate earlier detection and intervention, potentially reducing cardiovascular complications.
- Inform development of new therapeutic strategies and patient education for better management of kidney disease.
Abstract:
Chronic kidney disease (CKD) affects two to four million people in France and most of them are not aware of their disease. CKD is a major, independent risk factor of cardiovascular mortality and morbidity; the cardiovascular risk increases with the severity of renal failure. Evaluation of renal function (GFR) relies on MDRD and CKD-EPI equations. The French CKD-REIN cohort with more than 3000 patients followed for 5 years, will hopefully provide substantial advances in the knowledge of CKD epidemiology, of risk factors and mechanisms of CKD progression and medical practices. Improving CKD screening based on blood pressure, proteinuria (microalbuminuria in diabetic patients) and serum creatinine, is a national duty in high risk patients (with diabetes, hypertension and cardiovascular diseases). A major research goal is to identify new therapeutic targets and biomarkers, in order to treat kidney diseases before the occurrence of renal insufficiency, to halt their progression and to decrease cardiovascular risk. Careful therapeutic education of patients is required to successfully implement established guidelines, appropriate diets and new therapeutic strategies.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant I: Introduction
Diabetic Nephropathy
Nephrotic Syndrome II : Assessment and Medical Management
